Compare ImmunityBio Inc. Common Stock (IBRX) vs Intercontinental Exchange Inc. Common Stock (ICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Intercontinental Exchange Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B), while Intercontinental Exchange Inc. Common Stock trades at $155.35 (market cap $87.21B). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 8.3× ImmunityBio Inc. Common Stock's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.34% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IBRX | ICE | |
|---|---|---|
Market Cap | $10.51B | $87.21B |
Volume | 10,445,785 | 2,029,112 |
Sector | Health | Financials |
52-Week High | $11.55 | $175.10 |
52-Week Low | $1.98 | $122.91 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $10.97B | $105.12B |
Dividend Yield | — | 1.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Intercontinental Exchange Inc. Common Stock
Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →
